Pricing Log in Create free account

Heron Therapeutics, Inc. (HRTX) vs MAIA Biotechnology, Inc. (MAIA)

Heron Therapeutics, Inc. and MAIA Biotechnology, Inc. are both Biotechnology companies. Heron Therapeutics, Inc. and MAIA Biotechnology, Inc. are of similar size ($71.5M and $69.2M). MAIA Biotechnology, Inc. has the higher net margin (0.00% vs −22.5%) and the higher return on invested capital (0.00% vs −6.35%). Across the 13 metrics below, MAIA Biotechnology, Inc. leads on 8 and Heron Therapeutics, Inc. on 5.

Valuation

Metric HRTX MAIA Biotechnology median
P/E n/m n/m 8.50
P/S 0.45 n/m 9.71
P/B 11.70 3.23 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 1.11 n/m 9.21
Earnings yield (52.78%) (57.25%) (33.15%)
Free cash flow yield (17.64%) (33.75%) (25.50%)

Profitability

Metric HRTX MAIA Biotechnology median
Gross margin 70.07% — 65.16%
Operating margin (7.19%) 0.00% 0.00%
Net margin (22.52%) 0.00% 0.00%
Free cash flow margin (8.00%) 0.00% 0.00%
Return on equity 318.21% (218.68%) (56.36%)
Return on assets (14.06%) (136.67%) (48.04%)
Return on invested capital (6.35%) 0.00% 0.00%

Growth

Metric HRTX MAIA Biotechnology median
Revenue growth (TTM) 0.99% — 6.02%
EPS growth (last fiscal year) (33.33%) 33.33% 30.26%
Revenue growth, 5-year CAGR 11.81% — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric HRTX MAIA Biotechnology median
Debt to equity 20.65 0.00 0.00
Current ratio 2.49 4.51 4.72
Net debt to EBITDA (643.88) 0.36 0.96

Dividend

Metric HRTX MAIA Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric HRTX MAIA Biotechnology median
Market cap 71.48m 69.15m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack